{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:54:50Z","timestamp":1795107290574,"version":"4.10.3"},"reference-count":50,"publisher":"American Society of Hematology","issue":"22","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,25]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Recombination activating gene 1 (RAG1) is essential for variable diversity joining recombination during early T- and B-cell development. Null mutations cause a complete block in receptor rearrangement, resulting in T\u2013B\u2013 severe combined immunodeficiency (SCID). Patients with RAG1-SCID require hematopoietic stem cell transplantation for survival. Our phase I\/II clinical trial (NCT04797260) is currently evaluating lentiviral RAG1 gene addition in autologous hematopoietic stem and progenitor cells (HSPCs). However, studying early human T-cell development is challenging due to limited access to thymic tissue. The artificial thymic organoid (ATO) system offers a promising in vitro model to study human T-cell differentiation. Here, we show that ATO cultures efficiently support T-cell development from healthy donor HSPCs derived from umbilical cord blood or mobilized peripheral blood, yielding not only \u03b1\u03b2 but also \u03b3\u03b4 T cells with a polyclonal T-cell receptor (TCR) repertoire. In contrast, noncorrected RAG1-deficient HSPCs from 3 RAG1-SCID patients show a developmental arrest before or at the aberrant CD4+CD8dim double-positive stage, characterized by minimal or absent CD1a upregulation and CD7 downregulation, absence of TCR\u03b2 rearrangement, and only partial TCR\u03b3 and TCR\u03b4 rearrangement. Lentiviral RAG1 gene addition using the clinical vector rescues T-cell development in these patient-derived HSPCs and restores TCR repertoire diversity. These findings highlight the ATO system as a valuable model for dissecting human T-cell development and for the preclinical development and evaluation of gene therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016970","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T20:07:01Z","timestamp":1755634021000},"page":"5920-5934","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["RAG1 lentiviral gene therapy restores T-cell development of RAG1-SCID patient cells in artificial thymic organoids"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-3144","authenticated-orcid":false,"given":"Xiaolin","family":"Meng","sequence":"first","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-7194","authenticated-orcid":false,"given":"Janine E.","family":"Melsen","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"2Department of Pediatrics, Stem Cell Transplantation Program and Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"van der Holst","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Mooij","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vloemans","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"van Eggermond","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"Berghuis","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Stem Cell Transplantation Program and Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan C.","family":"Lankester","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Stem Cell Transplantation Program and Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-7802","authenticated-orcid":false,"given":"Sander","family":"de Kivit","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"3Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Pike-Overzet","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2078-3220","authenticated-orcid":false,"given":"Anton W.","family":"Langerak","sequence":"additional","affiliation":[{"name":"4Department of Immunology, Laboratory Medical Immunology, Erasmus Medical Center, University Medical Center, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1588-8519","authenticated-orcid":false,"given":"Frank J. T.","family":"Staal","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"2Department of Pediatrics, Stem Cell Transplantation Program and Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"3Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5608-2728","authenticated-orcid":false,"given":"Lisa M.","family":"Ott de Bruin","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"2Department of Pediatrics, Stem Cell Transplantation Program and Laboratory for Pediatric Immunology, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"3Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0418-8445","authenticated-orcid":false,"given":"Kirsten","family":"Cant\u00e9-Barrett","sequence":"additional","affiliation":[{"name":"1Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"3Novo Nordisk Foundation Centre for Stem Cell Medicine (reNEW), Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"4","key":"2025112509112768200_bib1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nri.2016.28","article-title":"Human RAG mutations: biochemistry and clinical implications","volume":"16","author":"Notarangelo","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"2025112509112768200_bib2","doi-asserted-by":"crossref","first-page":"106931","DOI":"10.1016\/j.imlet.2024.106931","article-title":"Gene therapy strategies for RAG1 deficiency: challenges and breakthroughs","volume":"270","author":"Gilioli","year":"2024","journal-title":"Immunol Lett"},{"issue":"11","key":"2025112509112768200_bib3","doi-asserted-by":"crossref","first-page":"12962","DOI":"10.18632\/oncotarget.7341","article-title":"Rapid generation of novel models of RAG1 deficiency by CRISPR\/Cas9-induced mutagenesis in murine zygotes","volume":"7","author":"Ott de Bruin","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"2025112509112768200_bib4","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1182\/bloodadvances.2020001730","article-title":"Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia","volume":"4","author":"Bosticardo","year":"2020","journal-title":"Blood Adv"},{"issue":"6","key":"2025112509112768200_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2015-10-676304","article-title":"Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies","volume":"128","author":"Brauer","year":"2016","journal-title":"Blood"},{"key":"2025112509112768200_bib6","doi-asserted-by":"crossref","first-page":"1210818","DOI":"10.3389\/fimmu.2023.1210818","article-title":"The recombinase activating genes: architects of immune diversity during lymphocyte development","volume":"14","author":"Braams","year":"2023","journal-title":"Front Immunol"},{"issue":"3","key":"2025112509112768200_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2017-12-820985","article-title":"Hypomorphic Rag1 mutations alter the preimmune repertoire at early stages of lymphoid development","volume":"132","author":"Ott de Bruin","year":"2018","journal-title":"Blood"},{"issue":"4","key":"2025112509112768200_bib8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2013.10.007","article-title":"A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency","volume":"133","author":"Lee","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2025112509112768200_bib9","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2018.04.027","article-title":"Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype","volume":"143","author":"Tirosh","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2025112509112768200_bib10","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jaci.2013.11.028","article-title":"Similar recombination-activating gene (RAG) mutations result in similar immunobiological effects but in different clinical phenotypes","volume":"133","author":"IJspeert","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2025112509112768200_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1084\/jem.20151116","article-title":"Intestinal microbiota sustains inflammation and autoimmunity induced by hypomorphic RAG defects","volume":"213","author":"Rigoni","year":"2016","journal-title":"J Exp Med"},{"issue":"1","key":"2025112509112768200_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/imr.12713","article-title":"RAG gene defects at the verge of immunodeficiency and immune dysregulation","volume":"287","author":"Villa","year":"2019","journal-title":"Immunol Rev"},{"issue":"1","key":"2025112509112768200_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","article-title":"Human inborn errors of immunity: 2019 update of the IUIS phenotypical classification","volume":"40","author":"Bousfiha","year":"2020","journal-title":"J Clin Immunol"},{"issue":"2","key":"2025112509112768200_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaci.2022.10.022","article-title":"The diagnosis of severe combined immunodeficiency (SCID): the Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 definitions","volume":"151","author":"Dvorak","year":"2023","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2025112509112768200_bib15","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"2025112509112768200_bib16","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"issue":"5","key":"2025112509112768200_bib17","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.jaci.2021.10.017","article-title":"Hematopoietic cell transplantation in severe combined immunodeficiency: the SCETIDE 2006-2014 European cohort","volume":"149","author":"Lankester","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2025112509112768200_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/ACI.0000000000000952","article-title":"Advances in gene therapy for inborn errors of immunity","volume":"23","author":"Ott de Bruin","year":"2023","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"9","key":"2025112509112768200_bib19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/leu.2011.106","article-title":"Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer","volume":"25","author":"Pike-Overzet","year":"2011","journal-title":"Leukemia"},{"key":"2025112509112768200_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.omtm.2020.03.016","article-title":"Successful preclinical development of gene therapy for recombinase-activating gene-1-deficient SCID","volume":"17","author":"Garcia-Perez","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"1","key":"2025112509112768200_bib21","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaci.2014.04.033","article-title":"Successful RAG1-SCID gene therapy depends on the level of RAG1 expression","volume":"134","author":"Pike-Overzet","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"2025112509112768200_bib22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3390\/biomedicines12071495","article-title":"Restoration of T and B cell differentiation after RAG1 gene transfer in human RAG1 defective hematopoietic stem cells","volume":"12","author":"Sorel","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"2025112509112768200_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.1998.tb01231.x","article-title":"Early stages in the development of human T, natural killer and thymic dendritic cells","volume":"165","author":"Spits","year":"1998","journal-title":"Immunol Rev"},{"issue":"8","key":"2025112509112768200_bib24","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2005-08-3412","article-title":"Human thymus contains multipotent progenitors with T\/B lymphoid, myeloid, and erythroid lineage potential","volume":"107","author":"Weerkamp","year":"2006","journal-title":"Blood"},{"key":"2025112509112768200_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fimmu.2017.00032","article-title":"Loss of CD44dim expression from early progenitor cells marks T-cell lineage commitment in the human thymus","volume":"8","author":"Cant\u00e9-Barrett","year":"2017","journal-title":"Front Immunol"},{"issue":"77","key":"2025112509112768200_bib26","doi-asserted-by":"crossref","first-page":"eade0182","DOI":"10.1126\/sciimmunol.ade0182","article-title":"Single-cell immune profiling reveals thymus-seeding populations, T cell commitment, and multilineage development in the human thymus","volume":"7","author":"Cordes","year":"2022","journal-title":"Sci Immunol"},{"issue":"5","key":"2025112509112768200_bib27","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nmeth.4237","article-title":"Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids","volume":"14","author":"Seet","year":"2017","journal-title":"Nat Methods"},{"issue":"103","key":"2025112509112768200_bib28","doi-asserted-by":"crossref","first-page":"eadq1697","DOI":"10.1126\/sciimmunol.adq1697","article-title":"Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature","volume":"10","author":"Bosticardo","year":"2025","journal-title":"Sci Immunol"},{"issue":"10","key":"2025112509112768200_bib29","doi-asserted-by":"crossref","first-page":"e20230892","DOI":"10.1084\/jem.20230892","article-title":"Rediscovering the human thymus through cutting-edge technologies","volume":"221","author":"Pala","year":"2024","journal-title":"J Exp Med"},{"issue":"12","key":"2025112509112768200_bib30","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1182\/bloodadvances.2020001736","article-title":"Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency","volume":"4","author":"Bifsha","year":"2020","journal-title":"Blood Adv"},{"issue":"4","key":"2025112509112768200_bib31","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jaci.2024.12.1082","article-title":"Thymic and T-cell intrinsic critical roles associated with severe combined immunodeficiency and Omenn syndrome due to a heterozygous variant (G201R) in PSMB10","volume":"155","author":"Kuehn","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"2025112509112768200_bib32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.04.021","article-title":"Probing the diagnosis of SCID through in vitro T-cell development: experience in 2 centers in North America","author":"Soulard","year":"25  2025","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2025112509112768200_bib33","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s10875-021-00989-6","article-title":"Gene editing rescues in vitro T cell development of RAG2-deficient induced pluripotent stem cells in an artificial thymic organoid system","volume":"41","author":"Gardner","year":"2021","journal-title":"J Clin Immunol"},{"issue":"7","key":"2025112509112768200_bib34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.cell.2023.02.027","article-title":"Human T cell generation is restored in CD3\u03b4 severe combined immunodeficiency through adenine base editing","volume":"186","author":"McAuley","year":"2023","journal-title":"Cell"},{"issue":"7-8","key":"2025112509112768200_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/hum.2023.100","article-title":"CRISPR\/Cas9-based disease modeling and functional correction of interleukin 7 receptor alpha severe combined immunodeficiency in T-lymphocytes and hematopoietic stem cells","volume":"35","author":"Rai","year":"2024","journal-title":"Hum Gene Ther"},{"issue":"6","key":"2025112509112768200_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/pharmaceutics12060549","article-title":"Preclinical development of autologous hematopoietic stem cell-based gene therapy for immune deficiencies: a journey from mouse cage to bed side","volume":"12","author":"Garcia-Perez","year":"2020","journal-title":"Pharmaceutics"},{"key":"2025112509112768200_bib37","doi-asserted-by":"crossref","first-page":"607991","DOI":"10.3389\/fimmu.2020.607991","article-title":"A novel branched DNA-based flowcytometric method for single-cell characterization of gene therapy products and expression of therapeutic genes","volume":"11","author":"Garcia-Perez","year":"2020","journal-title":"Front Immunol"},{"issue":"3","key":"2025112509112768200_bib38","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4049\/jimmunol.1901530","article-title":"A comprehensive workflow for applying single-cell clustering and pseudotime analysis to flow cytometry data","volume":"205","author":"Melsen","year":"2020","journal-title":"J Immunol"},{"key":"2025112509112768200_bib39","unstructured":"Kolde\n              R\n            \n          . Pheatmap: Pretty Heatmaps. R Package Version 1.0.12. Accessed 25 August 2025. https:\/\/cran.rproject.org\/package=pheatmap."},{"issue":"12","key":"2025112509112768200_bib40","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"3","key":"2025112509112768200_bib41","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.1097\/HS9.0000000000000255","article-title":"A new and simple TRG multiplex PCR assay for assessment of T-cell clonality: a comparative study from the EuroClonality Consortium","volume":"3","author":"Armand","year":"2019","journal-title":"Hemasphere"},{"issue":"2","key":"2025112509112768200_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaci.2024.10.018","article-title":"Newborn screening for SCID and severe T lymphocytopenia in Europe","volume":"155","author":"Blom","year":"2025","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"2025112509112768200_bib43","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1172\/JCI25221","article-title":"A variant of SCID with specific immune responses and predominance of gamma delta T cells","volume":"115","author":"Ehl","year":"2005","journal-title":"J Clin Invest"},{"key":"2025112509112768200_bib44","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clim.2018.11.006","article-title":"Increased proportions of \u03b3\u03b4 T lymphocytes in atypical SCID associate with disease manifestations","volume":"201","author":"Tometten","year":"2019","journal-title":"Clin Immunol"},{"issue":"11","key":"2025112509112768200_bib45","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1172\/JCI25178","article-title":"A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection","volume":"115","author":"de Villartay","year":"2005","journal-title":"J Clin Invest"},{"issue":"11","key":"2025112509112768200_bib46","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20042524","article-title":"New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling","volume":"201","author":"Dik","year":"2005","journal-title":"J Exp Med"},{"issue":"2","key":"2025112509112768200_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.stemcr.2019.12.010","article-title":"iPSC-based modeling of RAG2 severe combined immunodeficiency reveals multiple T cell developmental arrests","volume":"14","author":"Themeli","year":"2020","journal-title":"Stem Cell Rep"},{"issue":"1","key":"2025112509112768200_bib48","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1038\/s41467-023-42036-5","article-title":"CRISPR-Cas9 engineering of the RAG2 locus via complete coding sequence replacement for therapeutic applications","volume":"14","author":"Allen","year":"2023","journal-title":"Nat Commun"},{"issue":"733","key":"2025112509112768200_bib49","doi-asserted-by":"crossref","first-page":"eadh8162","DOI":"10.1126\/scitranslmed.adh8162","article-title":"Exonic knockout and knockin gene editing in hematopoietic stem and progenitor cells rescues RAG1 immunodeficiency","volume":"16","author":"Castiello","year":"2024","journal-title":"Sci Transl Med"},{"key":"2025112509112768200_bib50","doi-asserted-by":"crossref","first-page":"1438383","DOI":"10.3389\/fimmu.2024.1438383","article-title":"Case report: artificial thymic organoids facilitate clinical decisions for a patient with a TP63 variant and severe persistent T cell lymphopenia","volume":"15","author":"Gall","year":"2024","journal-title":"Front Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/22\/5920\/2421091\/blooda_adv-2025-016970-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/22\/5920\/2421091\/blooda_adv-2025-016970-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:11:43Z","timestamp":1764079903000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/22\/5920\/546759\/RAG1-lentiviral-gene-therapy-restores-T-cell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":50,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025,11,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016970","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11,25]]},"published":{"date-parts":[[2025,11,17]]}}}